10 Great Cheap Stocks to Buy Now for Under $10 in 2019

Posted on Tuesday, March 26th, 2019 by MarketBeat Staff

As the P/E ratios of most S&P 500 companies look very expensive and the stock market continues to regularly hit new all-time highs, it's very difficult for investors to find cheap stocks to buy now.

This goes for both share price, since most stocks are trading higher on a per-share basis, and valuation relative to earnings. Right now, the typical S&P 500 company is trading at about 25 times forward-looking earnings. Histortically, S&P 500 companies have traded at about 15 times earnings in more normal markets.

While the S&P 500 as a whole is expensive, there are still a handful undervalued stocks that are trading at less than $10.00 per share. Value investing opportunities for value exist if you know where to look. Putting together a list of cheap stocks to buy now requires looking into some smaller, riskier, unloved or undiscovered parts of the market. These low-priced stocks might not look especially attractive today, but long-term investors stand to profit if they are willing to be patient and hold onto shares of these companies through multiple market cycles.

Some of these companies are great investing ideas because they're too small and too risky to attract the interest of most mutual funds and Wall Street money managers. Others have been beat up by the market after a period of slowing earnings and profits, but are now trying to turn around and bounce back.

In this list, you might find marijuana stocks, dividend-paying stocks, large-cap stocks, growth stocks, small-cap stocks and even some bitcoin stocks. While these low-priced stocks have a lot of differences, these 10 stock picks all share a common characteristic, a super-low share price of $10.00 or less.

#1 - Net 1 UEPS Technologies (NASDAQ:UEPS)

Stock Price: $3.76
P/E Ratio: 1.9
Consensus Rating: Buy
Ratings Breakdown: 3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $11.6667 (210.3% Upside)

Net 1 UEPS Technologies logoNet 1 UEPS Technologies, Inc. provides transaction processing services, financial inclusion products and services, and secure payment technologies in South Africa, the Republic of Korea, and internationally. The company develops and markets transaction processing solutions, including smart card-based alternative payment systems for the unbanked and under-banked populations of developing economies and for mobile transaction channels. It operates through three segments: South African Transaction Processing, International Transaction Processing, and Financial Inclusion and Applied Technologies. The South African Transaction Processing segment primarily offers welfare benefit distribution services for the South African government; and transaction processing for retailers, utilities, and banks. The International Transaction Processing segment offers payment processing services to merchants and card issuers. The Financial Inclusion and Applied Technologies segment provides short-term loans and bank accounts. It also sells prepaid products, such as electricity and airtime, hardware and software, and life insurance products. In addition, this segment distributes mobile subscriber starter packs; and provides financing and project management services to develop and maintain a tower network, as well as operates Money4Jam, a micro-jobbing platform that connects companies and job-seekers for the completion of micro-jobs through mobile phone technology. The company was founded in 1989 and is headquartered in Johannesburg, South Africa.

#2 - Entravision Communication (NYSE:EVC)

Stock Price: $3.35
P/E Ratio: 1.9
Dividend Yield: 6.01 %
Consensus Rating: Buy
Ratings Breakdown: 1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $6.00 (79.1% Upside)

Entravision Communication logoEntravision Communications Corporation operates as a media company that reaches and engages Hispanics across media channels and advertising platforms primarily in the United States, Spain, Mexico, Argentina, and other Latin America countries. The company operates through three segments: Television Broadcasting, Radio Broadcasting, and Digital Media. Its portfolio encompasses integrated marketing and media solutions comprising television, radio, and digital properties, as well as data analytics services. The company also provides a suite of digital advertising solutions, including the Headway digital programmatic advertising platform, the Mobrain mobile advertising platform, and the Pulpo media advertising network, which allows advertisers to reach and engage with their target audiences by providing access to premium digital inventory at scale across a wide range of devices. As of March 14, 2018, the company owned and operated 55 primary television stations; and 49 primarily Spanish-language radio stations. Entravision Communications Corporation was founded in 1996 and is headquartered in Santa Monica, California.

#3 - Lannett (NYSE:LCI)

Stock Price: $7.09
P/E Ratio: 2.3
Consensus Rating: Hold
Ratings Breakdown: 0 Buy Ratings, 6 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $21.8750 (208.5% Upside)

Lannett logoLannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages. It also provides its products for various medical indications comprising cholesterol, muscle spasm, pain management, irritable bowel, antipsychosis, gastrointestinal, cardiovascular, thyroid deficiency, central nervous system, urinary, migraine, bronchospasms, and gallstone. In addition, the company manufactures active pharmaceutical ingredients. It markets its products under the Lipitor, Lioresal, Bentyl, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Concerta, Toprol-XL, Prilosec, Ditropan, Protonix, Imitrex, Brethine, and Actigall brands to generic pharmaceutical and private label distributors, drug wholesalers, chain drug retailers, mail-order pharmacies, other pharmaceutical manufacturers, managed care and health maintenance organizations, hospital buying groups, and governmental entities. The company has supply and development agreements with Jerome Stevens Pharmaceuticals, Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, and Aralez Pharmaceuticals. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

#4 - Venator Materials (NYSE:VNTR)

Stock Price: $5.31
P/E Ratio: 2.4
Consensus Rating: Buy
Ratings Breakdown: 7 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
Consensus Price Target: $15.65 (194.7% Upside)

Venator Materials logoVenator Materials PLC manufactures and markets chemical products worldwide. It operates through two segments, Titanium Dioxide and Performance Additives. The Titanium Dioxide segment offers titanium dioxide (TiO2), such as rutile, anatase, and nano TiO2 products for use in coatings, plastics, paper, printing inks, fibers, and food and personal care products. The Performance Additives segment provides barium and zinc additives for use in coatings, films, pharmaceuticals, and paper and glass fiber reinforced plastics; colored inorganic pigments comprising iron oxides, ultramarines, specialty inorganics chemicals, and driers for construction, coating, plastic, and specialty markets; and wood protection chemicals for use in residential and commercial applications, as well as water treatment chemicals. The company was founded in 2017 and is headquartered in Stockton-On-Tees, the United Kingdom.

#5 - Select Income REIT (NASDAQ:SIR)

Stock Price: $7.36
P/E Ratio: 2.6
Dividend Yield: 27.72 %
Consensus Rating: Hold
Ratings Breakdown: 1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $26.00 (253.3% Upside)

Select Income REIT logoSIR is a real estate investment trust, or REIT, that owns directly or indirectly through its subsidiaries, including its majority owned subsidiary, ILPT, properties that are primarily net leased to single tenants. As of September 30, 2018, our consolidated portfolio included 368 buildings, leasable land parcels and easements with approximately 45.8 million rentable square feet located in 36 states. SIR owned 99 of these buildings and leasable land parcels with approximately 16.5 million rentable square feet, which are primarily office buildings, and ILPT owned 269 of these buildings, leasable land parcels and easements with approximately 29.2 million rentable square feet, including 226 buildings, leasable land parcels and easements with approximately 16.8 million rentable square feet which are primarily leasable industrial and commercial lands located in Hawaii. ILPT was our wholly owned subsidiary until January 17, 2018, when it completed an initial public offering, or the ILPT IPO, of its common shares and became a publicly traded REIT. We remain ILPT's largest shareholder and, as of the date hereof, we own 45.0 million, or approximately 69.2%, of ILPT's outstanding common shares. Pursuant to the Merger Agreement, we will, subject to the satisfaction of certain conditions, distribute all 45.0 million of the ILPT common shares that we own to our shareholders prior to the merger. We have been investment grade rated since 2014, and we are included in the Russell 2000® Index and the MSCI US REIT Index.

#6 - Endo International (NASDAQ:ENDP)

Stock Price: $8.21
P/E Ratio: 2.8
Consensus Rating: Hold
Ratings Breakdown: 6 Buy Ratings, 12 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $15.7333 (91.6% Upside)

Endo International logoEndo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals. The U.S. Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, abuse-deterrent products, liquids, semi-solids, patches, powders, ophthalmics, sprays, and sterile injectables, as well as products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The U.S. Branded Pharmaceuticals segment provides XIAFLEX for the treatment of Dupuytren's contracture and Peyronie's diseases; SUPPRELIN LA for central precocious puberty treatment; TESTOPEL, a long-acting implantable pellet for the treatment of central precocious puberty; NASCOBAL, a nasal spray to treat vitamin B12 deficiency; and AVEED for the treatment of hypogonadism. This segment also offers pain management products, such as PERCOCET, VOLTAREN Gel, and LIDODERM; TESTIM Gel for the treatment of endogenous testosterone; and FORTESTA Gel for hypogonadism treatment. The International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. It sells its branded pharmaceuticals and generics directly to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

#7 - Just Energy Group (NYSE:JE)

Stock Price: $3.44
P/E Ratio: 2.9
Dividend Yield: 11.08 %
Consensus Rating: Buy
Ratings Breakdown: 4 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $5.3720 (56.2% Upside)

Just Energy Group logoJust Energy Group Inc., through its subsidiaries, provides electricity, natural gas, and renewable energy solutions in the United States, Canada, the United Kingdom, Ireland, Germany, and Japan. It operates through Consumer Energy and Commercial Energy segments. The company offers various home and business energy solutions, including long-term fixed-price, variable-price, and flat-bill solutions to residential and commercial customers. It also provides solar energy solutions; carbon emissions solutions, such as green energy and carbon offsets and renewable energy credits; and smart thermostats and smart irrigation controllers. In addition, the company offers filters, LED light bulbs, and residential water sprinkler controllers; and home security, automation, and voice controlled devices. As of June 1, 2018, it served 1.6 million residential and commercial customers. The company markets its products through retailing, door-to-door marketing, brokers, independent contractors, sales representatives, online marketing, and others. The company was founded in 1997 and is headquartered in Mississauga, Canada.

#8 - Hi-Crush Partners (NYSE:HCLP)

Stock Price: $4.47
P/E Ratio: 3.0
Dividend Yield: 20.83 %
Consensus Rating: Hold
Ratings Breakdown: 2 Buy Ratings, 10 Hold Ratings, 5 Sell Ratings.
Consensus Price Target: $10.3214 (130.9% Upside)

Hi-Crush Partners logoHi-Crush Partners LP, together with its subsidiaries, provides proppant and logistics solutions to the petroleum industry in North America. The company offers raw frac sand used in hydraulic fracturing process for oil and natural gas wells. It owns and operates multiple frac sand mining facilities, which include a 971-acre facility with integrated rail infrastructure located in Wyeville, Wisconsin; a 1,187-acre facility with integrated rail infrastructure located in Eau Claire County, Wisconsin; a 1,285-acre facility with integrated rail infrastructure located in Blair, Wisconsin; and a 1,626-acre facility with integrated rail infrastructure located in Independence, Wisconsin and Whitehall, Wisconsin. The company also owns and operates a 1,226-acre frac sand reserve located near Kermit, Texas; and 12 terminal locations throughout Pennsylvania, Ohio, Texas, Colorado, and New York. It primarily serves pressure pumping service providers, and oil and gas exploration and production companies. Hi-Crush GP LLC operates as the general partner of the company. Hi-Crush Partners LP was founded in 2012 and is based in Houston, Texas.

#9 - Laredo Petroleum (NYSE:LPI)

Stock Price: $3.10
P/E Ratio: 3.3
Consensus Rating: Hold
Ratings Breakdown: 1 Buy Ratings, 6 Hold Ratings, 3 Sell Ratings.
Consensus Price Target: $6.8333 (120.4% Upside)

Laredo Petroleum logoLaredo Petroleum, Inc., an independent energy company, engages in the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas, the United States. The company also provides midstream and marketing services comprising transportation and marketing of oil and natural gas; and natural gas lift systems, crude oil and natural gas gathering, and water delivery and takeaway services. As of December 31, 2018, it had assembled 120,617 net acres in the Permian Basin; and had total proved reserves of 238,167 thousand barrels of oil equivalent. The company was formerly known as Laredo Petroleum Holdings, Inc. and changed its name to Laredo Petroleum, Inc. in December 2013. Laredo Petroleum, Inc. was founded in 2006 and is headquartered in Tulsa, Oklahoma.

#10 - PPDAI Group (NYSE:PPDF)

Stock Price: $3.87
P/E Ratio: 3.5
Consensus Rating: Hold
Ratings Breakdown: 0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target: $6.00 (55.0% Upside)

PPDAI Group logoPPDAI Group Inc., an investment holding company, operates an online consumer finance marketplace through its platform in the People's Republic of China. It provides services to match borrowers with investors and facilitate loan transactions on its marketplace through the lifecycle of loans. The company offers standard and other loan products; and investment services to investors. As of December 31, 2017, it had approximately 65 million cumulative registered users. The company was founded in 2007 and is headquartered in Shanghai, the People's Republic of China.





More on MarketBeat
13 Stocks Institutional Investors Won13 Stocks Institutional Investors Won't Stop Buying
Top Ten Brokerages You Can TrustTop Ten Brokerages You Can Trust
7 Dividend Stocks to Help Through Market Volatility7 Dividend Stocks to Help Through Market Volatility
7 Pharma Stocks to Avoid at All Costs7 Pharma Stocks to Avoid at All Costs
7 Blue-Chip Stocks that Could Take the Market Higher7 Blue-Chip Stocks that Could Take the Market Higher
12 Marijuana Stocks to Buy Now12 Marijuana Stocks to Buy Now
12 Cheap Dividend Stocks to Buy Today12 Cheap Dividend Stocks to Buy Today





Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel